3-Methoxy-2-isopropyl-propionsaeure-methylester | 90201-48-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 3-Methoxy-2-isopropyl-propionsaeure-methylester
• 英文别名: Methyl 2-(methoxymethyl)-3-methylbutanoate
• CAS: 90201-48-2
• 化学式: C₈H₁₆O₃
• 分子量: 160.213
• InChiKey: HLSPCXAHIVZUSU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• HETEROCYCLE AND CARBOCYCLE DERIVATIVES HAVING TRKA INHIBITORY ACTIVITY
  申请人：Shionogi & Co., Ltd.

  公开号：US20170240512A1

  公开（公告）日：2017-08-24

  The present invention relates to a compound represented by Formula (I): wherein -L- is —C(═X)—, or the like, —Z— is —NR 5 —, or the like, —Z A — is —NR 5A —, or the like, —W— is —C(R 8 R 9 )n-, —W A — is —C(R 3 R 4 )m-, B is substituted or unsubstituted aromatic carbocyclyl, or the like, Y is a bond, or the like, the ring C is a substituted or unsubstituted aromatic heterocycle, or the like, R 2 is a hydrogen atom, or the like, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising thereof.

  本发明涉及一种由式（I）表示的化合物：其中-L-为—C(═X)—，或类似的，—Z—为—NR5—，或类似的，—ZA—为—NR5A—，或类似的，—W—为—C(R8R9)n-，—WA—为—C(R3R4)m-，B为取代或未取代的芳香环烃基，或类似的，Y为键，或类似的，环C为取代或未取代的芳香杂环，或类似的，R2为氢原子，或类似的，或其药学上可接受的盐，或包括其的药物组成。
• OLEFIN POLYMERIZATION CATALYST, PROCESS FOR PRODUCING OLEFIN POLYMER, POLYPROPYLENE RESIN COMPOSITION AND ARTICLE COMPRISING THE SAME
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20130109789A1

  公开（公告）日：2013-05-02

  An olefin polymerization catalyst is obtained by bringing the following components (A), (B) and (C) into contact with one another: (A) a solid catalyst component for olefin polymerization containing a titanium atom, a magnesium atom and a halogen atom; (B) an organoaluminum compound; and (C) a triether represented by formula (I). An olefin polymerization solid catalyst can be provided having a sufficiently high polymerization activity and an ability to produce an olefin polymer with a low content of low-molecular weight components and amorphous components.

  一种烯烃聚合催化剂是通过将以下组分（A）、（B）和（C）彼此接触而获得的：（A）用于烯烃聚合的固体催化剂组分，其中包含钛原子、镁原子和卤素原子；（B）有机铝化合物；以及（C）由式（I）表示的三醚。可以提供具有足够高的聚合活性和能够产生低分子量成分和非晶态成分含量低的烯烃聚合物的固体聚合催化剂。
• PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
  申请人：Allen Shelley

  公开号：US20150166564A1

  公开（公告）日：2015-06-18

  Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R 1 , R 2 , R a , R b , R c , R d , X, Y, B, and Ring C are as defined herein, and wherein the Y—B moiety and the NH—C(═X)—NH moiety are in the trans configuration, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.

  化合物I的公式：或其立体异构体、互变异构体、药学上可接受的盐、溶剂或前药，其中R1、R2、Ra、Rb、Rc、Rd、X、Y、B和环C的定义如本文所述，其中Y-B基团和NH-C（═X）-NH基团处于反式构象，是TrkA激酶的抑制剂，可用于治疗可以通过TrkA激酶抑制剂治疗的疾病，例如疼痛、癌症、炎症、神经退行性疾病和某些传染病。
• PROCESS FOR PRODUCING SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION
  申请人：FUJIWARA Yasuki

  公开号：US20110269928A1

  公开（公告）日：2011-11-03

  The present invention aims at providing a solid catalyst component for olefin polymerization, the solid catalyst composed being capable of showing a sufficiently high polymerization activity and providing a polymer having a low content of a low molecular weight component or an amorphous component; a process for producing the solid catalyst component; and a process for producing a solid catalyst for olefin polymerization, and a process for producing an olefin polymer. This object can be achieved by a process for producing a solid catalyst component (A), the process including: step (1) of producing a precursor of the solid catalyst component by adding an organomagnesium compound (c) to a titanium compound (b) represented by Formula (I) in the presence of a silicon compound containing a Si—O bond (a); and step (2) of producing the solid catalyst component (A) by bringing the precursor of the solid catalyst component, a halogenated metal compound represented by Formula (II) and an internal electron donor represented by Formula (III) into contact with each other.
• PYRROLIDINYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
  申请人：ARRAY BIOPHARMA INC.

  公开号：US20160297758A1

  公开（公告）日：2016-10-13

  Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R 1 , R 2 , R a , R b , R c , R d , X, Ring B, and Ring C are as defined herein, and wherein Ring B moiety and the NH—C(═X)—NH moiety are in the trans configuration, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.